Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re‐radiotherapy

30 Aug 2024

Abstract excerpt

Local recurrence after radiotherapy is common in locally advanced head and neck cancer (HNC) patients. Re-irradiation can improve local disease control, but disease progression remains frequent. Hence, predictive biomarkers are needed to adapt treatment intensity to the patient's individual risk. We quantified circulating tumor DNA (ctDNA) in sequential plasma samples and correlated ctDNA levels with disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Diagnosis and Treatment
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39212345
DOI: 10.1002/ijc.35152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re‐radiotherapyPMID 39212345Read ↗

Tumour informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post-treatmentSemantic proximity Read ↗

Personalized circulating tumor DNA dynamics predict survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerSemantic proximity Read ↗

Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patientsSemantic proximity Read ↗

Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA.Semantic proximity Read ↗

Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer.Semantic proximity Read ↗

Next-Generation Sequencing of Plasma Cell-Free DNA for Treatment Monitoring in Advanced Head and Neck Cancer Patients.Semantic proximity Read ↗

Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study.Semantic proximity Read ↗

The molecular characteristics of recurrent/metastatic HPV-positive head and neck squamous cell carcinoma: A systematic review of the literatureSemantic proximity Read ↗

Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant ChemoradiotherapySemantic proximity Read ↗

Circulating tumour DNA alterations as biomarkers for head and neck cancer: a systematic review.Semantic proximity Read ↗

Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay.Semantic proximity Read ↗

Postoperative Lymph is a Proximal Source of ctDNA for Detection of Recurrence in HPV-independent Head and Neck CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.